Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wysa’s AI-driven mental health app has been validated in clinical trials and peer-reviewed studies, showing efficacy comparable to human therapists in forming therapeutic emotional bonds. The platform is used globally and has received FDA Breakthrough Device Designation for its use as an adjunct in treating chronic musculoskeletal pain with associated depression and anxiety. It is certified as a CE Class 1 Medical Device and meets NHS DCB 0129 standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wysa.